Michael Tagen

2.4k total citations
33 papers, 1.7k citations indexed

About

Michael Tagen is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Michael Tagen has authored 33 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 15 papers in Oncology and 10 papers in Immunology. Recurrent topics in Michael Tagen's work include Cancer therapeutics and mechanisms (7 papers), Mast cells and histamine (7 papers) and Glioma Diagnosis and Treatment (3 papers). Michael Tagen is often cited by papers focused on Cancer therapeutics and mechanisms (7 papers), Mast cells and histamine (7 papers) and Glioma Diagnosis and Treatment (3 papers). Michael Tagen collaborates with scholars based in United States, Italy and United Kingdom. Michael Tagen's co-authors include Theoharis C. Theoharides, Duraisamy Kempuraj, Pio Conti, Dimitris Kalogeromitros, Clinton F. Stewart, Magdalini Vasiadi, Ángel M. Carcaboso, Charles H. Fraga, Karen Hubbard and Mohamed Elmeliegy and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and The Journal of Immunology.

In The Last Decade

Michael Tagen

32 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Tagen United States 19 695 479 354 262 174 33 1.7k
Valentina Pucino United Kingdom 22 838 1.2× 919 1.9× 307 0.9× 309 1.2× 80 0.5× 40 2.5k
Caroline Coisne Switzerland 20 901 1.3× 666 1.4× 502 1.4× 204 0.8× 69 0.4× 24 2.7k
Eun Mi Hur United States 12 916 1.3× 748 1.6× 355 1.0× 116 0.4× 95 0.5× 13 2.4k
Michele C. Madigan Australia 38 515 0.7× 1.6k 3.3× 302 0.9× 115 0.4× 65 0.4× 142 4.1k
Jilin Sun United States 16 297 0.4× 718 1.5× 411 1.2× 160 0.6× 72 0.4× 26 1.7k
Maria Sofia Basile Italy 30 556 0.8× 755 1.6× 194 0.5× 170 0.6× 82 0.5× 63 1.8k
Ningping Feng United States 23 451 0.6× 607 1.3× 521 1.5× 193 0.7× 69 0.4× 65 1.7k
Robert C. Axtell United States 20 893 1.3× 1.5k 3.0× 347 1.0× 172 0.7× 79 0.5× 28 2.8k
Sandra J. Campbell United Kingdom 25 416 0.6× 901 1.9× 193 0.5× 119 0.5× 49 0.3× 40 2.2k
Angela Cattaneo Italy 24 359 0.5× 1.1k 2.2× 259 0.7× 272 1.0× 88 0.5× 45 2.1k

Countries citing papers authored by Michael Tagen

Since Specialization
Citations

This map shows the geographic impact of Michael Tagen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Tagen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Tagen more than expected).

Fields of papers citing papers by Michael Tagen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Tagen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Tagen. The network helps show where Michael Tagen may publish in the future.

Co-authorship network of co-authors of Michael Tagen

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Tagen. A scholar is included among the top collaborators of Michael Tagen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Tagen. Michael Tagen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Klumpers, Linda E., et al.. (2024). Tolerability of High-Dose Oral Δ 9 -THC: Implications for Human Laboratory Study Design. Cannabis and Cannabinoid Research. 9(2). 437–448.
2.
Chimalakonda, Anjaneya, James R. Burke, Lihong Cheng, et al.. (2021). Selectivity Profile of the Tyrosine Kinase 2 Inhibitor Deucravacitinib Compared with Janus Kinase 1/2/3 Inhibitors. Dermatology and Therapy. 11(5). 1763–1776. 88 indexed citations
3.
Varga, Andréa, Jean‐Charles Soria, Antoine Hollebecque, et al.. (2019). A First-in-Human Phase I Study to Evaluate the ERK1/2 Inhibitor GDC-0994 in Patients with Advanced Solid Tumors. Clinical Cancer Research. 26(6). 1229–1236. 64 indexed citations
4.
Rothenberg, Michael E., Michael Tagen, Jae H. Chang, et al.. (2019). Safety, Tolerability, and Pharmacokinetics of GDC-0276, a Novel NaV1.7 Inhibitor, in a First-in-Human, Single- and Multiple-Dose Study in Healthy Volunteers. Clinical Drug Investigation. 39(9). 873–887. 30 indexed citations
5.
Stewart, Clinton F., et al.. (2014). Phase I dosage finding and pharmacokinetic study of intravenous topotecan and oral erlotinib in adults with refractory solid tumors. Cancer Chemotherapy and Pharmacology. 73(3). 561–568. 9 indexed citations
6.
Blaney, Susan M., Michael Tagen, Arzu Onar‐Thomas, et al.. (2012). A phase‐1 pharmacokinetic optimal dosing study of intraventricular topotecan for children with neoplastic meningitis: A pediatric brain tumor consortium study. Pediatric Blood & Cancer. 60(4). 627–632. 15 indexed citations
7.
McGregor, Lisa M., Clinton F. Stewart, Kristine R. Crews, et al.. (2011). Dose escalation of intravenous irinotecan using oral cefpodoxime: A phase I study in pediatric patients with refractory solid tumors. Pediatric Blood & Cancer. 58(3). 372–379. 24 indexed citations
8.
Elmeliegy, Mohamed, Ángel M. Carcaboso, Michael Tagen, Feng Bai, & Clinton F. Stewart. (2010). Role of ATP-Binding Cassette and Solute Carrier Transporters in Erlotinib CNS Penetration and Intracellular Accumulation. Clinical Cancer Research. 17(1). 89–99. 88 indexed citations
9.
Tagen, Michael, et al.. (2010). Stability of Cyclophosphamide in Extemporaneous Oral Suspensions. Annals of Pharmacotherapy. 44(2). 295–301. 15 indexed citations
10.
Tagen, Michael, Yanli Zhuang, Fan Zhang, et al.. (2010). P-Glycoprotein, but not Multidrug Resistance Protein 4, Plays a Role in the Systemic Clearance of Irinotecan and SN-38 in Mice. Drug Metabolism Letters. 4(4). 195–201. 29 indexed citations
11.
Zhang, Bodi, Asimenia Angelidou, Duraisamy Kempuraj, et al.. (2010). TNF secretion from human mast cells is regulated by mitochondrial dynamics and mitochondrial uncoupling protein 2 (UCP2) (135.11). The Journal of Immunology. 184(Supplement_1). 135.11–135.11. 5 indexed citations
12.
Bai, Feng, et al.. (2010). Determination of the γ-secretase inhibitor MK-0752 in human plasma by online extraction and electrospray tandem mass spectrometry (HTLC–ESI-MS/MS). Journal of Chromatography B. 878(25). 2348–2352. 7 indexed citations
13.
Zhang, Fan, Michael Tagen, Stacy L. Throm, et al.. (2010). Whole-Body Physiologically Based Pharmacokinetic Model for Nutlin-3a in Mice after Intravenous and Oral Administration. Drug Metabolism and Disposition. 39(1). 15–21. 46 indexed citations
14.
Shen, Jun, Ángel M. Carcaboso, Karen Hubbard, et al.. (2009). Compartment-Specific Roles of ATP-Binding Cassette Transporters Define Differential Topotecan Distribution in Brain Parenchyma and Cerebrospinal Fluid. Cancer Research. 69(14). 5885–5892. 42 indexed citations
15.
16.
17.
Bai, Feng, Fangyi Zhu, Michael Tagen, et al.. (2009). Determination of nutlin-3a in murine plasma by liquid chromatography electrospray ionization tandem mass spectrometry (LC–ESI-MS/MS). Journal of Pharmaceutical and Biomedical Analysis. 51(4). 915–920. 6 indexed citations
18.
Kempuraj, D., Michael Tagen, Anthony Clemons, et al.. (2008). Luteolin inhibits myelin basic protein‐induced human mast cell activation and mast cell‐dependent stimulation of Jurkat T cells. British Journal of Pharmacology. 155(7). 1076–1084. 87 indexed citations
19.
Castellani, M.L., Michael Tagen, Duraisamy Kempuraj, et al.. (2007). Anti-Chemokine Therapy for Inflammatory Diseases. International Journal of Immunopathology and Pharmacology. 20(3). 447–453. 40 indexed citations
20.
Theoharides, Theoharis C., Duraisamy Kempuraj, Michael Tagen, Pio Conti, & Dimitris Kalogeromitros. (2007). Differential release of mast cell mediators and the pathogenesis of inflammation. Immunological Reviews. 217(1). 65–78. 341 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Valentina Pucino Breakdown of academic impact, for papers by Caroline Coisne Breakdown of academic impact, for papers by Eun Mi Hur Breakdown of academic impact, for papers by Michele C. Madigan Breakdown of academic impact, for papers by Jilin Sun Breakdown of academic impact, for papers by Maria Sofia Basile Breakdown of academic impact, for papers by Ningping Feng Breakdown of academic impact, for papers by Robert C. Axtell Breakdown of academic impact, for papers by Sandra J. Campbell Breakdown of academic impact, for papers by Angela Cattaneo
Rankless by CCL
2026